Delivery Order SPE2DB20D3103-SPE2DB24FL8D9

Award Date 12/6/23
Potential Completion Date 12/7/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,289.35 firm-fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,740.30 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.96 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $1,757.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, with an ultimate completion date of January 17, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,593.98 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 24, 2023 and was awarded on January 23, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.30 Firm Fixed Price Delivery Order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used for the treatment of diabetes. The contract has an ultimate completion date of March 4, 2025 and was awarded on March 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,558.83 Firm Fixed Price Delivery Order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products. The contract has an ultimate completion date of March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,219.97 Firm Fixed Price Delivery Order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used for diabetes management. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This award is associated with Amerisourcebergen's Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a specialty pharmaceutical product, with a ceiling value of $3,857.20. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,236.75 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL8D9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.44 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a comprehensive vehicle for providing pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this specific award.

Generated 2/27/25, 10:12 AM